"In-silico rituximab protein engineering to improve humanisation and ..."

Harit Kasana, Harish Chander, Ashwani Mathur (2024)

> Home

Details and statistics

DOI: 10.1504/IJBRA.2024.138716

access: closed

type: Journal Article

metadata version: 2024-07-02

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/ijbra/KasanaCM24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/ijbra/KasanaCM24
Harit Kasana, Harish Chander, Ashwani Mathur:
In-silico rituximab protein engineering to improve humanisation and reduce immunogenicity. Int. J. Bioinform. Res. Appl. 20(2): 142-160 (2024)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.